More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability

(MedPage Today) — BARCELONA — Chimeric antigen receptor (CAR) T-cell therapy for rheumatologic disease is now expanding out of academe into the commercial space, with encouraging new data reported here from a U.S.-based industry program.
A…

Source link : https://www.medpagetoday.com/meetingcoverage/eular/116040

Author :

Publish date : 2025-06-12 17:57:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability

Patients With Pretreated DME May Need More Frequent Aflibercept Injections

Investigational Long-Acting Drug Safe in Phenotypic MASH

Related Posts

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

Human trials point the way towards an mRNA vaccine against HIV

Categories

Archives